StockData
Axogen, Inc. logo

Axogen, Inc. (AXGN) stock

AXGNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/30142% above fair value
$55.37−0.01 (-0.02%)

Close on Nov 17, 2026Market cap $3.31BP/E –Yield –

Axogen price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Axogen's price to sales ratio was 12.5× on Nov 11, 2026, against 6.2× a year earlier. Over the last 5 years it ranged from 1.1× to 12.5×, with a median of 3.1×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202612.5×+5.5
2025Dec 31, 20257.0×+3.0
2024Dec 31, 20244.0×+2.1
2023Dec 29, 20231.9×−1.2
2022Dec 30, 20223.1×+0.1
2021Dec 31, 20213.0×−3.6
2020Dec 31, 20206.7×−0.3
2019Dec 31, 20196.9×−3.3
2018Dec 31, 201810.2×−7.0
2017Dec 29, 201717.2×+10.0
2016Dec 30, 20167.2×+1.1
2015Dec 31, 20156.1×+2.0
2014Dec 31, 20144.2×−3.6
2013Dec 31, 20137.8×+3.5
2012Dec 31, 20124.3×−2.6
2011Dec 30, 20116.9×–

More Axogen figures

See a number that looks wrong?